Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |